Bruker (BRKR) Common Equity (2010 - 2026)

Bruker (BRKR) has reported Common Equity for 17 consecutive years, with $2.4 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 31.92% year-over-year to $2.4 billion; the trailing twelve-month figure through Jun 2026 stood at $2.4 billion (up 31.92% YoY), and the FY2025 full-year result was $2.5 billion, up 37.64% from the prior year.
• Common Equity declined to $2.4 billion in Q2 2026 per BRKR's latest filing, from $2.5 billion in the prior quarter.
• Across five years, Common Equity topped out at $2.5 billion in Q4 2025 and bottomed at $948.0 million in Q3 2022.
• Historically, Common Equity has averaged $1.6 billion across 5 years, with a median of $1.6 billion in 2024.
• The sharpest annual moves came in 2022 and 2024: Common Equity decreased 13.0% in 2022, then soared 48.73% in 2024.
• Over 5 years, Common Equity stood at $1.1 billion in 2022, then climbed by 23.89% to $1.4 billion in 2023, then gained by 28.86% to $1.8 billion in 2024, then soared by 37.64% to $2.5 billion in 2025, then fell by 2.96% to $2.4 billion in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $2.4 billion, $2.5 billion, and $2.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.